PITUITARY CARCINOMA

Clinical trials for PITUITARY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PITUITARY CARCINOMA trials appear

Sign up with your email to follow new studies for PITUITARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Immunotherapy combo shows promise for tough pituitary tumors

Disease control Completed

This phase 2 trial tested two immunotherapy drugs, nivolumab and ipilimumab, in 10 patients with aggressive pituitary tumors that worsened after surgery and radiation. The goal was to see if the combination could shrink tumors or slow their growth. Researchers also monitored side…

Matched conditions: PITUITARY CARCINOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

PITUITARY CARCINOMA

Get alerted when new PITUITARY CARCINOMA trials appear

Immunotherapy combo shows promise for tough pituitary tumors